Image

Circadian Timing and Time Perception in Healthy Adults

Circadian Timing and Time Perception in Healthy Adults

Recruiting
23-45 years
All
Phase N/A

Powered by AI

Overview

This study examines how a person's natural daily rhythm ("chronotype") affects the way time is experienced and judged. Healthy Danish-speaking adults (23-45 years) who are clearly morning-type or evening-type will complete two lab sessions in a crossover design: one at their preferred time of day (e.g., morning for morning-types) and one at the opposite time (misaligned). In each session, participants do brief computerized tasks that measure time estimation/production, vigilance (psychomotor vigilance task), decision-making, and responses to social information, plus simple color-vision tasks. Short questionnaires about sleepiness, mood, fatigue, and the subjective "passage of time" are collected before, during, and after testing. A subset will wear a wrist actigraphy device for one week beforehand to characterize sleep-wake patterns.

Testing is conducted under standardized lab conditions with scheduled breaks. The main goal is to determine whether time judgments and vigilance are less accurate during the misaligned session and whether decision-making and social responses also vary with circadian timing. Risks are minimal and mainly relate to temporary tiredness when tested at a non-preferred time; participants may stop at any time. Participation is voluntary. Data are pseudonymized and handled under GDPR. Participants receive DKK 300 after completing both sessions (pro-rated if they withdraw early). Results will be published regardless of outcome, and de-identified data/code will be shared after publication.This study examines how a person's natural daily rhythm ("chronotype") affects the way time is experienced and judged. Healthy Danish-speaking adults (23-45 years) who are clearly morning-type or evening-type will complete two lab sessions in a crossover design: one at their preferred time of day (e.g., morning for morning-types) and one at the opposite time (misaligned). In each session, participants do brief computerized tasks that measure time estimation/production, vigilance (psychomotor vigilance task), decision-making, and responses to social information, plus simple color-vision tasks. Short questionnaires about sleepiness, mood, fatigue, and the subjective "passage of time" are collected before, during, and after testing. A subset will wear a wrist actigraphy device for one week beforehand to characterize sleep-wake patterns.

Testing is conducted under standardized lab conditions with scheduled breaks. The main goal is to determine whether time judgments and vigilance are less accurate during the misaligned session and whether decision-making and social responses also vary with circadian timing. Risks are minimal and mainly relate to temporary tiredness when tested at a non-preferred time; participants may stop at any time. Participation is voluntary. Data are pseudonymized and handled under GDPR. Participants receive DKK 300 after completing both sessions (pro-rated if they withdraw early). Results will be published regardless of outcome, and de-identified data/code will be shared after publication.

Description

Background/Rationale. Circadian rhythms vary across individuals (chronotypes) and can be misaligned with social schedules. Both circadian timing and time perception influence cognition and behavior, yet within-person effects of circadian alignment on temporal judgments and related functions are not well characterized.

Objectives/Hypotheses. Primary: test whether circadian misalignment (testing at a non-preferred time) increases time-estimation/production bias and reduces vigilance versus aligned testing. Secondary: assess effects on temporal variability, duration discrimination, decision-making strategies, social conformity, and simple color-perception measures (white-point/unique-hue).

Design. Randomized, two-condition crossover trial with within-subject comparison of circadian-congruent vs incongruent sessions (order counterbalanced). Sessions occur on the same day (morning and evening) with a substantial break; no visible clocks; caffeine/exercise restrictions prior to testing. A subset (n≈60) completes 7-day actigraphy and sleep diary.

Participants. Healthy adults, 23-45 years, Danish-speaking, clear morning or evening chronotype (MEQ/MCTQ). Key exclusions: shift work, recent trans-meridian travel, sleep/neurologic/psychiatric disorders, medications affecting sleep/cognition, intermediate chronotype.

Intervention. Behavioral manipulation of testing time relative to chronotype (congruent vs incongruent) in a crossover design.

Outcomes.

Primary: (1) Time-estimation/production bias across 10-60 s targets; (2) Psychomotor vigilance task (lapses, RT).

Secondary: Time-estimation variability (CV), duration discrimination threshold, passage-of-time ratings, KSS sleepiness, mood/fatigue scales, information-conformity effect, decision-making metrics, color-perception indices (white-point/unique-hue).

Outcome time frame: per session; within-subject contrast (incongruent-congruent).

Sample size/Analysis. Target N≈128. Within-subject models test condition effects, with chronotype and session order as factors; missing data handled with mixed-effects models. Alpha=0.05 (two-sided).

Data management/Sharing. Pseudonymized data stored per AU policy/GDPR. De-identified datasets and analysis code will be shared in an open repository within 12 months of primary publication.

Risk/Benefit. Minimal risk (temporary tiredness). Potential benefits include improved understanding of circadian influences on cognition with implications for scheduling and performance.

Eligibility

Inclusion Criteria:

  • Aged 23 to 45 years
  • Able to understand and communicate in Danish
  • Completed at least upper secondary education (e.g., gymnasium)
  • Categorized as either a Morning Type (MT) or Evening Type (ET) based on standardized chronotype assessments:
    • Munich Chronotype Questionnaire (MCTQ):
      • MT: sleep midpoint on free days (MSFsc) ≤ 03:00
      • ET: sleep midpoint on free days (MSFsc) ≥ 05:00
    • Morningness-Eveningness Questionnaire (MEQ):
      • One of four defined chronotype categories (definitely morning, moderately morning, moderately evening, definitely evening).

Exclusion Criteria:

  • Current engagement in shift work, rotating schedules, or other forms of irregular sleep-wake timing
  • Diagnosis of any neurological, psychiatric, or sleep-related disorder (e.g., insomnia, narcolepsy, sleep apnea)
  • Use of medications that affect sleep, alertness, or circadian functioning (e.g., melatonin, stimulants, antidepressants)
  • International travel across time zones within the four weeks preceding study participation
  • Are classified as having an intermediate chronotype based on validated chronotype assessments (MCTQ or MEQ), as this group does not provide the necessary contrast to evaluate circadian alignment effects.

Study details
    Circadian Rhythm
    Time Perception

NCT07292597

University of Aarhus

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.